Results 101 to 110 of about 1,441,473 (315)

An extension of A-stability to alternating direction implicit methods [PDF]

open access: yes
An alternating direction implicit (ADI) scheme was constructed by the method of approximate factorization. An A-stable linear multistep method (LMM) was used to integrate a model two-dimensional hyperbolic-parabolic partial differential equation ...
Beam, R. M., Warming, R. F.
core   +1 more source

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

open access: yesMolecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova   +18 more
wiley   +1 more source

About Fokker-Planck equation with measurable coefficients and applications to the fast diffusion equation [PDF]

open access: yes, 2012
The object of this paper is the uniqueness for a $d$-dimensional Fokker-Planck type equation with non-homogeneous (possibly degenerated) measurable not necessarily bounded coefficients. We provide an application to the probabilistic representation of the
Belaribi, Nadia, Russo, Francesco
core   +4 more sources

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

open access: yesMolecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu   +12 more
wiley   +1 more source

The Extended Trial Equation Method for Some Time Fractional Differential Equations

open access: yesDiscrete Dynamics in Nature and Society, 2013
Nonlinear fractional partial differential equations have been solved with the help of the extended trial equation method. Based on the fractional derivative in the sense of modified Riemann-Liouville derivative and traveling wave transformation, the ...
Yusuf Pandir   +2 more
doaj   +1 more source

Adjoint Methods for the Infinity Laplacian Partial Differential Equation

open access: yes, 2011
To study fine properties of certain smooth approximations $${u^\varepsilon}$$ to a viscosity solution u of the infinity Laplacian partial differential equation (PDE), we introduce Green’s function $${\sigma^\varepsilon}$$ for the linearization.
L. Evans, Charles K. Smart
semanticscholar   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte   +10 more
wiley   +1 more source

Numerical Solution of Elliptic Partial Differential Equation: Method of Lines and Crank-Nicholson Method

open access: yesPan-American Journal of Mathematics
The method of lines (MOL) is a solution procedure for solving partial differential equation (PDE) and the Crank-Nicholson method (CNM) is an implicit finite difference method, used to solve the elliptic equation and similar partial differential equations
Md Roknujjaman   +2 more
doaj   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy